Elutia Inc.

Healthcare · Medical Devices · United States

Last price 0.8371 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 37.07M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local antibiotic delivery. The company provides SimpliDerm, a human acellular dermal matrix used in soft tissue reconstruction. It also offers ProxiCor for cardiac tissue repair for use as an intracardiac pat...